Bank Of Montreal Cara Therapeutics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$7.45 - $13.84 $82,136 - $152,586	-11,025 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$9.94 - $12.65 $4,761 - $6,059	-479 Reduced 4.16%	11,025 $133,000
Q4 2021 Feb 11, 2022	SELL	$11.99 - $18.14 $149,803 - $226,641	-12,494 Reduced 52.06%	11,504 $146,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $33,437 - $46,493	2,895 Added 13.72%	23,998 $370,000
Q2 2021 Aug 12, 2021	BUY	$12.38 - $29.19 $261,255 - $615,996	21,103 New	21,103 $309,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $247M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.